These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23533578)

  • 1. Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose.
    Mendy M; Peterson I; Hossin S; Peto T; Jobarteh ML; Jeng-Barry A; Sidibeh M; Jatta A; Moore SE; Hall AJ; Whittle H
    PLoS One; 2013; 8(3):e58029. PubMed ID: 23533578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
    Peto TJ; Mendy ME; Lowe Y; Webb EL; Whittle HC; Hall AJ
    BMC Infect Dis; 2014 Jan; 14():7. PubMed ID: 24397793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of compulsory and booster doses of hepatitis B vaccine among children in Cairo, Egypt.
    Salama I; Sami S; Saleh R; Mohsen A; Elserougy S; Emam H; Said Z
    J Egypt Public Health Assoc; 2017 Jun; 92(2):77-85. PubMed ID: 30184404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children.
    Whittle H; Jaffar S; Wansbrough M; Mendy M; Dumpis U; Collinson A; Hall A
    BMJ; 2002 Sep; 325(7364):569. PubMed ID: 12228132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
    Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
    Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence.
    van der Sande MA; Waight PA; Mendy M; Zaman S; Kaye S; Sam O; Kahn A; Jeffries D; Akum AA; Hall AJ; Bah E; McConkey SJ; Hainaut P; Whittle HC
    PLoS One; 2007 Aug; 2(8):e753. PubMed ID: 17710152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further observations on the immune response to recombinant hepatitis B vaccine after administration to aboriginal and Torres Strait Island children.
    Hanna JN; Faoagali JL; Buda PJ; Sheridan JW
    J Paediatr Child Health; 1997 Feb; 33(1):67-70. PubMed ID: 9069048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term protection against carriage of hepatitis B virus after infant vaccination.
    van der Sande MA; Waight P; Mendy M; Rayco-Solon P; Hutt P; Fulford T; Doherty C; McConkey SJ; Jeffries D; Hall AJ; Whittle HC
    J Infect Dis; 2006 Jun; 193(11):1528-35. PubMed ID: 16652281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Booster Response to Hepatitis B Vaccine at 15 years of age: A Cross-Sectional School-Based Study.
    Chen YS; Chu CH; Wang JH; Lin JS; Chang YC
    Pediatr Neonatol; 2016 Aug; 57(4):302-9. PubMed ID: 26750404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
    Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
    BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of maternal carrier status on immunologic markers for protection after hepatitis B vaccination in infancy: a meta-analysis.
    Schönberger K; Riedel C; Rückinger S; Mansmann U; Jilg W; von Kries R
    Vaccine; 2012 Sep; 30(44):6314-26. PubMed ID: 22885275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.